Logo image of EDT.CA

SPECTRAL MEDICAL INC (EDT.CA) Stock Fundamental Analysis

Canada - TSX:EDT - CA8475771033 - Common Stock

1.41 CAD
+0.06 (+4.44%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

1

EDT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 22 industry peers in the Biotechnology industry. Both the profitability and financial health of EDT have multiple concerns. While showing a medium growth rate, EDT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EDT has reported negative net income.
In the past year EDT has reported a negative cash flow from operations.
In the past 5 years EDT always reported negative net income.
In the past 5 years EDT always reported negative operating cash flow.
EDT.CA Yearly Net Income VS EBIT VS OCF VS FCFEDT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

EDT's Return On Assets of -388.99% is on the low side compared to the rest of the industry. EDT is outperformed by 77.27% of its industry peers.
Industry RankSector Rank
ROA -388.99%
ROE N/A
ROIC N/A
ROA(3y)-227.94%
ROA(5y)-174.27%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EDT.CA Yearly ROA, ROE, ROICEDT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

Looking at the Gross Margin, with a value of 54.23%, EDT belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
In the last couple of years the Gross Margin of EDT has declined.
EDT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.21%
GM growth 5Y-10.46%
EDT.CA Yearly Profit, Operating, Gross MarginsEDT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

EDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EDT has been increased compared to 1 year ago.
Compared to 5 years ago, EDT has more shares outstanding
The debt/assets ratio for EDT is higher compared to a year ago.
EDT.CA Yearly Shares OutstandingEDT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EDT.CA Yearly Total Debt VS Total AssetsEDT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

EDT has an Altman-Z score of -46.21. This is a bad value and indicates that EDT is not financially healthy and even has some risk of bankruptcy.
EDT has a worse Altman-Z score (-46.21) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -46.21
ROIC/WACCN/A
WACC7.86%
EDT.CA Yearly LT Debt VS Equity VS FCFEDT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

2.3 Liquidity

EDT has a Current Ratio of 0.12. This is a bad value and indicates that EDT is not financially healthy enough and could expect problems in meeting its short term obligations.
EDT has a Current ratio of 0.12. This is in the lower half of the industry: EDT underperforms 68.18% of its industry peers.
EDT has a Quick Ratio of 0.12. This is a bad value and indicates that EDT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EDT (0.11) is worse than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.11
EDT.CA Yearly Current Assets VS Current LiabilitesEDT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

EDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.70%.
EDT shows a decrease in Revenue. In the last year, the revenue decreased by -4.31%.
EDT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.08% yearly.
EPS 1Y (TTM)-42.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-4.31%
Revenue growth 3Y-8.7%
Revenue growth 5Y-16.08%
Sales Q2Q%37.71%

3.2 Future

The Earnings Per Share is expected to grow by 26.51% on average over the next years. This is a very strong growth
Based on estimates for the next years, EDT will show a very strong growth in Revenue. The Revenue will grow by 106.89% on average per year.
EPS Next Y-23.87%
EPS Next 2Y21.21%
EPS Next 3Y8.92%
EPS Next 5Y26.51%
Revenue Next Year23.53%
Revenue Next 2Y18.82%
Revenue Next 3Y47.79%
Revenue Next 5Y106.89%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EDT.CA Yearly Revenue VS EstimatesEDT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
EDT.CA Yearly EPS VS EstimatesEDT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 0 0.2 0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EDT. In the last year negative earnings were reported.
Also next year EDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDT.CA Price Earnings VS Forward Price EarningsEDT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDT.CA Per share dataEDT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.21%
EPS Next 3Y8.92%

More info and screens

0

5. Dividend

5.1 Amount

EDT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPECTRAL MEDICAL INC

TSX:EDT (11/14/2025, 7:00:00 PM)

1.41

+0.06 (+4.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-25 2026-03-25/bmo
Inst Owners0.04%
Inst Owner ChangeN/A
Ins Owners1.54%
Ins Owner ChangeN/A
Market Cap406.00M
Revenue(TTM)1.60M
Net Income(TTM)-21.38M
Analysts83.33
Price Target3.16 (124.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.81%
PT rev (3m)14.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 160.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -388.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.23%
FCFM N/A
ROA(3y)-227.94%
ROA(5y)-174.27%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.21%
GM growth 5Y-10.46%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.54%
Cap/Sales 6.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.11
Altman-Z -46.21
F-Score4
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)35.44%
Cap/Depr(5y)73.91%
Cap/Sales(3y)4.85%
Cap/Sales(5y)10.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-23.87%
EPS Next 2Y21.21%
EPS Next 3Y8.92%
EPS Next 5Y26.51%
Revenue 1Y (TTM)-4.31%
Revenue growth 3Y-8.7%
Revenue growth 5Y-16.08%
Sales Q2Q%37.71%
Revenue Next Year23.53%
Revenue Next 2Y18.82%
Revenue Next 3Y47.79%
Revenue Next 5Y106.89%
EBIT growth 1Y31.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.57%
OCF growth 3YN/A
OCF growth 5YN/A

SPECTRAL MEDICAL INC / EDT.CA FAQ

What is the ChartMill fundamental rating of SPECTRAL MEDICAL INC (EDT.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EDT.CA.


What is the valuation status of SPECTRAL MEDICAL INC (EDT.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to SPECTRAL MEDICAL INC (EDT.CA). This can be considered as Overvalued.


What is the profitability of EDT stock?

SPECTRAL MEDICAL INC (EDT.CA) has a profitability rating of 1 / 10.


What is the financial health of SPECTRAL MEDICAL INC (EDT.CA) stock?

The financial health rating of SPECTRAL MEDICAL INC (EDT.CA) is 0 / 10.